AKAM three-lens brief
Evidence-based stock research on AKAM. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Underperforming SPY by 10.4pp over 30 days.
- Underperforming SPY by 10.4pp over 30 days.
- Analyst mean target $159.30 — 23% above current (23 analysts).
- Earnings scheduled 2026-08-06.
AKAM closed at $129.93 (+0.32%) as of 2026-07-10. Market cap: $18.89B. P/E (trailing) 43.7. Price is below the 50-day MA and above the 200-day MA. Positives: analyst mean target $159.30 — 23% above current (23 analysts).. Concerns: underperforming SPY by 10.4pp over 30 days.. Last quarter: Revenue $1.07B, net income $106.32M, free cash flow $700.72M. Watching for: 2026-08-06 earnings release (26 days out).
Why three lenses on AKAM, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AKAMacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AKAM" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AKAM brief"></iframe>